It is a pharma private limited company based in Goa, Goa, India, established in 1993.
1993 | Goa, Goa, India | ActiveShwarde Pharmaceuticals (India) Private Limited, a active private limited company, was established on 17 June 1993 in Goa, Goa, India. Engaging in pharmaceutical retailers & distributors within the manufacturing sector, it holds CIN: U24234GA1993PTC001374. Registered under ROC Roc Goa. it is unlisted. It has an authorized capital of ₹1.25 Cr and a paid-up capital of ₹1.24 Cr.
It upholds a compliant status. Its leadership includes Prakash Rajaram Hede (Director), Arvind Shamsunder Amonkar (Director), Rohan Prakash Hede (Director). Past directors included Rohan Prakash Hede. It holds ₹5.79 Cr open charges and ₹1.80 Cr settled loans. Its latest AGM occurred on 30 September 2024, with the balance sheet filed on 31 March 2024. It is based at House No 844,Alto Betim Porvorim, Goa, Goa, 403521.
U24234GA1993PTC001374
001374
17 June 1993
₹1.25 Cr
₹1.24 Cr
Roc Goa
Unlisted
Active
Explore comprehensive insights into Shwarde Pharmaceuticals (India) Private Limited — covering financial performance, compliance records, Competitor, shareholding patterns, directors, key metrics, and litigation history. Unlock to see detailed insights and stay informed.
Access Report
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
| Prakash Rajaram Hede | Director | 30 Nov 1994 | Current |
| Arvind Shamsunder Amonkar | Director | 11 Jun 2019 | Current |
| Rohan Prakash Hede | Director | 28 Dec 2020 | Current |
| Name | Designation | Cessation | Status |
|---|---|---|---|
| Pramod Abcsdd | Director | 13 Jun 2019 | Past |
Discover detailed profiles of directors and KMP - Unlock leadership insights today!
Shwarde Pharmaceuticals (India) Private Limited, for the financial year ended 2023, experienced significant reduction in revenue, with a 99.29% decrease. The company also saw a substantial improvement in profitability, with a 34.04% increase in profit. The company's net worth witnessed no change by increase of 0%.
| Metrics |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth | |||||||
| EBITDA |
|
Unlock access to Shwarde Pharmaceuticals (India)'s control and ownership data, Corporate Shareholding Patterns, Funding (security allotment) details, Foreign Institutional Investor information, Directors and Key Management Personnel (KMP) Remuneration, Group Structure, Overseas Direct Investment and other pertinent data.
Reveal ownership structures and financial performance - Get instant access now!
₹57,875,000.00
₹18,000,000.00
| Date | Lender | Amount | Status |
|---|---|---|---|
| 11 Oct 2005 | Canara Bank | ₹4.00 M | Open |
| 30 Nov 2004 | Canara Bank | ₹1.58 M | Open |
| 29 Mar 2003 | Canara Bank | ₹2.50 M | Open |
| 09 Apr 2002 | Canara Bank | ₹3.43 Cr | Open |
| 09 Apr 2002 | Canara Bank | ₹1.25 Cr | Open |
Explore comprehensive loan charge details -
Unlock and access historical data on people associated with Shwarde Pharmaceuticals (India), such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Gain comprehensive insights into the Deals and Valuation data of Shwarde Pharmaceuticals (India), offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Shwarde Pharmaceuticals (India)'s trajectory.
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
Shwarde Pharmaceuticals (India) Private Limited last Annual general meeting of members was held on 30 Sep 2024 as per latest MCA records. was recorded as a recent event.
Progress on Shwarde Pharmaceuticals (India) Private Limited has filed its annual Financial statements for the year ended 31 Mar 2024 with Roc Goa. was documented.
The activity Rohan Prakash Hede was appointed as a Director was appointed as a Director on 28 Dec 2020 & has been associated with this company since 4 years 11 months . was completed.
The activity Arvind Shamsunder Amonkar was appointed as a Director was appointed as a Director on 11 Jun 2019 & has been associated with this company since 6 years 5 months . was completed.
The activity A charge registered on 22 May 2013 via Charge ID 10430402 with The Madgaum Urban Cooperative Bank Limited was fully satisfied on 07 Jun 2019. was completed.
A charge with The Madgaum Urban Cooperative Bank Limited amounted to Rs. 1.80 Cr with Charge ID 10430402 was registered on 22 May 2013. was recorded as a recent event.
The CIN of Shwarde Pharmaceuticals (India) Private Limited is U24234GA1993PTC001374.
Shwarde Pharmaceuticals (India) Private Limited is headquartered at House No 844,Alto Betim Porvorim, Goa, Goa, 403521.
Shwarde Pharmaceuticals (India) Private Limited was incorporated on 17 June 1993.
The current directors of Shwarde Pharmaceuticals (India) Private Limited are
The primary industry of Shwarde Pharmaceuticals (India) Private Limited is Manufacturing.
Shwarde Pharmaceuticals (India) Private Limited is unlisted.
The authorized capital of Shwarde Pharmaceuticals (India) Private Limited is ₹1.25 Cr, and the paid-up capital is ₹1.24 Cr.
The compliance status of Shwarde Pharmaceuticals (India) Private Limited is Compliant.
Search company & director profiles for free and gain access to critical business data.
Company Details
+91-XXXXXXXXXX